ArticleExperimental & applied acarology2025
Acaricidal activity of Astragalus polysaccharides nanoemulsion against camel tick, Hyalomma dromedarii.
Article in Experimental & applied acarology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hyalomma dromedarii (H. dromedarii) is a major ectoparasite of camels in arid regions such as Egypt, where it causes significant economic losses and transmits several zoonotic pathogens. This study evaluated the acaricidal efficacy of a novel, locally prepared Astragalus polysaccharides nanoemulsified formulation (APS-NE) against various developmental stages of H. dromedarii infesting camels. APS-NE was prepared using ultrasonic emulsification and characterized by dynamic light scattering, transmission electron microscopy, and GC-MS, revealing uniform nanoparticle size (30-53 nm), good water solubility, and bioactive constituents including palmitic acid and quercetin derivatives. The formulation exhibited strong biological activity with very low toxicity and a wide safety margin in mice. In vitro bioassays showed a clear concentration-dependent acaricidal effect following short immersion periods: at 2% APS-NE, mortality reached 100% for eggs, larvae, nymphs, and unfed adults. Mortality rates at lower concentrations (0.5-1.5%) ranged from 63.6% to 94.6% in eggs, 33.6% to 84.3% in larvae, 53.3% to 93.6% in nymphs, and 31% to 87% in unfed adults, with larvae being the most susceptible stage. APS-NE also significantly impaired reproductive parameters in engorged females, including reductions in egg production index, egg mass, and hatchability compared to the reference drug. Strong positive correlations were observed between APS-NE concentration and tick mortality, with negative correlations for reproductive metrics. These results highlight APS-NE as a safe, eco-friendly alternative to conventional acaricides for effective H. dromedarii control, supporting integrated tick management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.